FDA.reportPublic FDA data

Application 202334

Type
ANDA
Sponsor
PERRIGO R AND D

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LEVONORGESTRELLEVONORGESTRELTABLET;ORAL1.5MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0113-2003Option 2levonorgestrelL. Perrigo CompanyANDACurrent
0113-2003Option 2levonorgestrelL. Perrigo CompanyANDACurrent
11509-0067PreventezalevonorgestrelCombe IncorporatedANDACurrent
69953-514Morning AfterLevonorgestrelRapha Pharmaceuticals, Inc.ANDACurrent
69953-514Morning AfterLevonorgestrelRapha Pharmaceuticals, Inc.ANDACurrent
80584-100Stix RestartlevonorgestrelGet Stix Inc.ANDACurrent